Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.
Männistö
P T
PT
Department of Pharmacology and Toxicology, University of Helsinki, Finland.
Kaakkola
S
S
D000818:Animals; D065098:Catechol O-Methyltransferase Inhibitors; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D065098:Catechol O-Methyltransferase Inhibitors